检测,模式和结果的复发性HPV阳性口腔甲状腺状细胞癌
Rema Shah1,2, Sarah G Wilkins1,2, Conrad W Safranek1,2
1Yale University School of Medicine, New Haven, Connecticut.
JAMA otolaryngology-- head & neck surgery
|October 17, 2024
概括
复发的人类乳头瘤病毒 (HPV) 阳性口腔状细胞癌 (OPSCC) 影响10.1%的患者,通常通过症状检测,而不是成像. 为了找到最佳的监控策略,还需要进一步的研究.
科学领域:
- 在瘤学瘤学.
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 放射学 放射学是一门学科.
背景情况:
- 复发性人类乳头瘤病毒 (HPV) 阳性口腔状细胞癌 (OPSCC) 是一种罕见但严重的疾病,数据有限.
- 现有的关于HPV阳性OPSCC复发的研究还没有系统地分析治疗后监视成像策略或检测方法.
研究的目的:
- 改进对HPV阳性OPSCC中复发模式的理解.
- 为制定最佳的成像监测策略提供信息,以进行治疗后的随访.
主要方法:
- 以第三级护理医院的电子病历作为回顾性队列研究.
- 从2012年至2019年期间接受OPSCC治疗的患者的数据分析,重点关注HPV阳性病例.
- 从2022年12月到2023年5月进行的数据分析.
主要成果:
- 在367名HPV阳性OPSCC患者中,有10.1%的患者经历了真正的疾病复发.
- 局部,区域或局部和区域复发 (LRR) 在56.8%的复发病例中发生,而远程转移 (DM) 在40.5%中发生.
- 复发主要通过患者报告的症状 (81.1%) 而不是监视成像 (8.1%) 检测到.
结论:
- 在HPV阳性OPSCC中,真正的疾病复发发生在10.1%的病例中,远程转移经常涉及肺和大脑.
- 目前的监测方法似乎不足,因为大多数复发是通过症状变化来识别的,而不是常规成像.
- 对最佳监测策略的进一步调查是有必要的,以改善复发性HPV阳性OPSCC的早期检测.
更多相关视频
06:57Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
10.3K
07:43Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
Published on: July 29, 2017
9.6K
相关概念视频
Mechanisms of Retrovirus-induced Cancers
5.0K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.0K
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
